Literature DB >> 28708043

Reirradiation spine stereotactic body radiation therapy for spinal metastases: systematic review.

Sten Myrehaug1, Arjun Sahgal1, Motohiro Hayashi2, Marc Levivier3, Lijun Ma4, Roberto Martinez5, Ian Paddick6, Jean Régis7, Samuel Ryu8, Ben Slotman9, Antonio De Salles10.   

Abstract

OBJECTIVE Spinal metastases that recur after conventional palliative radiotherapy have historically been difficult to manage due to concerns of spinal cord toxicity in the retreatment setting. Spine stereotactic body radiation therapy (SBRT), also known as stereotactic radiosurgery, is emerging as an effective and safe means of delivering ablative doses to these recurrent tumors. The authors performed a systematic review of the literature to determine the clinical efficacy and safety of spine SBRT specific to previously irradiated spinal metastases. METHODS A systematic literature review was conducted, which was specific to SBRT to the spine, using MEDLINE, Embase, Cochrane Evidence-Based Medicine Database, National Guideline Clearinghouse, and CMA Infobase, with further bibliographic review of appropriate articles. Research questions included: 1) Is retreatment spine SBRT efficacious with respect to local control and symptom control? 2) Is retreatment spine SBRT safe? RESULTS The initial literature search retrieved 2263 articles. Of these articles, 160 were potentially relevant, 105 were selected for in-depth review, and 9 studies met all inclusion criteria for analysis. All studies were single-institution series, including 4 retrospective, 3 retrospective series of prospective databases, 1 prospective, and 1 Phase I/II prospective study (low- or very low-quality data). The results indicated that spine SBRT is effective, with a median 1-year local control rate of 76% (range 66%-90%). Improvement in patients' pain scores post-SBRT ranged from 65% to 81%. Treatment delivery was safe, with crude rates of vertebral body fracture of 12% (range 0%-22%) and radiation-induced myelopathy of 1.2%. CONCLUSIONS This systematic literature review suggests that SBRT to previously irradiated spinal metastases is safe and effective with respect to both local control and pain relief. Although the evidence is limited to low-quality data, SBRT can be a recommended treatment option for reirradiation.

Entities:  

Keywords:  BPI = Brief Pain Inventory; CR = complete response; ISRS = International Stereotactic Radiosurgery Society; SBRT = stereotactic body radiotherapy; VCF = vertebral compression fracture; cEBRT = conventional palliative fractionated external-beam radiotherapy; metastases; oncology; retreatment; spine; stereotactic radiation; vertebral body

Mesh:

Year:  2017        PMID: 28708043     DOI: 10.3171/2017.2.SPINE16976

Source DB:  PubMed          Journal:  J Neurosurg Spine        ISSN: 1547-5646


  28 in total

1.  Local control and patterns of failure for "Radioresistant" spinal metastases following stereotactic body radiotherapy compared to a "Radiosensitive" reference.

Authors:  K Liang Zeng; Arjun Sahgal; Zain A Husain; Sten Myrehaug; Chia-Lin Tseng; Jay Detsky; Arman Sarfehnia; Mark Ruschin; Mikki Campbell; Monica Foster; Sunit Das; Nir Lipsman; Georg A Bjarnason; Eshetu G Atenafu; Pejman Jabehdar Maralani; Hany Soliman
Journal:  J Neurooncol       Date:  2021-01-16       Impact factor: 4.130

2.  Proton density fat fraction (PDFF) MRI for differentiation of benign and malignant vertebral lesions.

Authors:  Frederic Carsten Schmeel; Julian Alexander Luetkens; Peter Johannes Wagenhäuser; Michael Meier-Schroers; Daniel Lloyd Kuetting; Andreas Feißt; Jürgen Gieseke; Leonard Christopher Schmeel; Frank Träber; Hans Heinz Schild; Guido Matthias Kukuk
Journal:  Eur Radiol       Date:  2018-01-08       Impact factor: 5.315

3.  Stereotactic radiosurgery training patterns across neurosurgical programs: a multi-national survey.

Authors:  Nardin Samuel; Daniel M Trifiletti; Alfredo Quinones-Hinojosa; L Dade Lunsford; Jason Sheehan
Journal:  J Neurooncol       Date:  2021-01-04       Impact factor: 4.130

4.  A comparison of stereotactic body radiation therapy for metastases to the sacral spine and treatment of the thoracolumbar spine.

Authors:  Roman O Kowalchuk; Michael R Waters; K Martin Richardson; Kelly Spencer; James M Larner; Jason P Sheehan; William H McAllister; Charles R Kersh
Journal:  J Radiosurg SBRT       Date:  2020

5.  Repeat reirradiation of the spinal cord: multi-national expert treatment recommendations.

Authors:  Carsten Nieder; Laurie E Gaspar; Dirk De Ruysscher; Matthias Guckenberger; Minesh P Mehta; Chad G Rusthoven; Arjun Sahgal; Eleni Gkika
Journal:  Strahlenther Onkol       Date:  2018-01-23       Impact factor: 3.621

Review 6.  Appropriate endpoints for stereotactic body radiotherapy for bone metastasis: Classification into five treatment groups.

Authors:  Kei Ito; Naoki Nakamura; Takuya Shimizuguchi; Hiroaki Ogawa; Katsuyuki Karasawa
Journal:  Rep Pract Oncol Radiother       Date:  2019-12-18

7.  Intensity-modulated radiation therapy administered to a previously irradiated spine is effective and well-tolerated.

Authors:  H Doi; K Tamari; N Masai; Y Akino; D Tatsumi; H Shiomi; R-J Oh
Journal:  Clin Transl Oncol       Date:  2020-06-05       Impact factor: 3.405

8.  Treatment planning for spinal radiosurgery : A competitive multiplatform benchmark challenge.

Authors:  Christos Moustakis; Mark K H Chan; Jinkoo Kim; Joakim Nilsson; Alanah Bergman; Tewfik J Bichay; Isabel Palazon Cano; Savino Cilla; Francesco Deodato; Raffaela Doro; Jürgen Dunst; Hans Theodor Eich; Pierre Fau; Ming Fong; Uwe Haverkamp; Simon Heinze; Guido Hildebrandt; Detlef Imhoff; Erik de Klerck; Janett Köhn; Ulrike Lambrecht; Britta Loutfi-Krauss; Fatemeh Ebrahimi; Laura Masi; Alan H Mayville; Ante Mestrovic; Maaike Milder; Alessio G Morganti; Dirk Rades; Ulla Ramm; Claus Rödel; Frank-Andre Siebert; Wilhelm den Toom; Lei Wang; Stefan Wurster; Achim Schweikard; Scott G Soltys; Samuel Ryu; Oliver Blanck
Journal:  Strahlenther Onkol       Date:  2018-05-25       Impact factor: 3.621

9.  Spinal metastasis: diagnosis, management and follow-up.

Authors:  Mahmud Mossa-Basha; Peter C Gerszten; Sten Myrehaug; Nina A Mayr; William Tc Yuh; Pejman Jabehdar Maralani; Arjun Sahgal; Simon S Lo
Journal:  Br J Radiol       Date:  2019-07-25       Impact factor: 3.039

Review 10.  Metastatic disease in head & neck oncology.

Authors:  Paolo Pisani; Mario Airoldi; Anastasia Allais; Paolo Aluffi Valletti; Mariapina Battista; Marco Benazzo; Roberto Briatore; Salvatore Cacciola; Salvatore Cocuzza; Andrea Colombo; Bice Conti; Alberto Costanzo; Laura Della Vecchia; Nerina Denaro; Cesare Fantozzi; Danilo Galizia; Massimiliano Garzaro; Ida Genta; Gabriela Alejandra Iasi; Marco Krengli; Vincenzo Landolfo; Giovanni Vittorio Lanza; Mauro Magnano; Maurizio Mancuso; Roberto Maroldi; Laura Masini; Marco Carlo Merlano; Marco Piemonte; Silvia Pisani; Adriele Prina-Mello; Luca Prioglio; Maria Gabriella Rugiu; Felice Scasso; Agostino Serra; Guido Valente; Micol Zannetti; Angelo Zigliani
Journal:  Acta Otorhinolaryngol Ital       Date:  2020-04       Impact factor: 2.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.